Epstein Secrets

g, too, ready to use that desperation to their advantage, federal investigators say." The AP adds, "Homeland Security investigators are working with Pfizer, Modema and dozens of other drug companies racing to complete and distribute the vaccine and treatments for the virus. The goal: to prepare for the

Surge After Holiday; Biden Names Economic Team; Trump Contests Election; Assassination Of Iranian Scientist. CBS: COVID Cases Surge After Holiday; Pfizer, Modena Seek Vaccine Approval; Trump Contests Election; Biden Names Economic Team; Assassination Of Iranian Scientist. NBC: COVID Cases Surge After

In an interview with the New York Times <https://vvwvv.nytimes.com/2020/11/30/health/covid-vaccine- modema.html> (11/30, Grady, 18.61M), Moderna CEO Stephane Bancel announced the first vaccinations "may be given as early as Dec. 21 if the process goes smoothly and approval is granted." Bancel told the Wall Stree

e House in the fight to end the pandemic." But "stocks of major pharmaceutical companies that have produced vaccines, including Modena, BioNTech and Pfizer, dropped sharply after news of the potential waivers first broke." Axios <https://www.axios.com/us-biden- vaccine-patents-waiver-65478c91-5107-41ff-

." The New York Times <https://www.nytimes.com/2021/05/05/science/moderna-booster-variants-covid.html> (5/5, Mandavilli, 20.6M) reports Moderna CEO Stephane Bancel said of the results, "We are encouraged by these new data, which reinforce our confidence that our booster strategy should be protective against the

House in the fight to end the pandemic." But "stocks of major pharmaceutical companies that have produced vaccines, induding Moderna, BioNTech and Pfizer, dropped sharply after news of the potential waivers first broke." Axios (5/5, Baker, 1.26M) says a waiver "would open the door for foreign manufact

wo weeks after the booster shots, and the trial is continuing to gather more data." The New York Times (5/5, Mandavilli, 20.6M) reports Moderna CEO Stephane Bancel said of the results, "We are encouraged by these new data, which reinforce our confidence that our booster strategy should be protective against th

House in the fight to end the pandemic." But "stocks of major pharmaceutical companies that have produced vaccines, including Modema, BioNTech and Pfizer, dropped sharply after news of the potential waivers first broke." Axios (5/5, Baker, 1.26M) says a waiver "would open the door for foreign manufac

wo weeks after the booster shots, and the trial is continuing to gather more data." The New York Times (5/5, Mandavilli, 20.6M) reports Moderna CEO Stephane Bancel said of the results, "We are encouraged by these new data, which reinforce our confidence that our booster strategy should be protective against th

re not going to do it that way, what we will do simultaneous development of the whole process,' and be ready so that if that vaccine from Novavax or Pfizer is ready to go, we would have tremendous bandwidth to manufacture at scale." Global Alliance Says Vaccine Should Cost No More Than $40 Per Shot. Re

unced it received an additional $472 million from the U.S. government to support the development of its potential coronavirus vaccine." Moderna CEO Stephane Bancel indicated Monday that "the results from Moderna's late-stage trial could be released as soon as October." The AP (7/27, Neergaard, Hill) has more d

re not going to do it that way, what we will do simultaneous development of the whole process,' and be ready so that if that vaccine from Novavax or Pfizer is ready to go, we would have tremendous bandwidth to manufacture at scale." Global Alliance Says Vaccine Should Cost No More Than $40 Per Shot. Re

unced it received an additional $472 million from the U.S. government to support the development of its potential coronavirus vaccine." Moderna CEO Stephane Bancel indicated Monday that "the results from Moderna's late-stage trial could be released as soon as October." The AP (7/27, Neergaard, Hill) has more d